As Bachem is the world’s leading company in developing and manufacturing peptides and oligonucleotides, we receive a lot of interest about our company news and activities.
Learn more about what is happening at Bachem, what activities we have coming up, and what events you can meet us both virtually and in-person.
All Bachem news
- All
- Ad-hoc
- CMC development
- Commercial APIs
- Featured news
- Finance
- Innovation
- Knowledge
- News
- Oligonucleotides
- Peptides
- Press
- Research & specialties
- Services & capabilities
- Sustainability
- Team
- Trends
Women’s Empowerment: “Women in Bachem” Community to Launch Soon
Bachem continues to grow and increases dividend
Our approach to remaining a leader in TIDES
What Are The Benefits of Partnering With a CDMO?
ISO recertification of Bachem’s St. Helens site in the UK
A conversation with the founders of ChromaCon
The era of large-scale peptide & oligo purification with MCSGP has begun
Jérôme Kaeslin receives ETH medal for his outstanding dissertation
Scalable tag-assisted one-pot liquid-phase oligo synthesis
Elena Zakharova Wins Cancer Drug Discovery Research Award
Back to stirred vessels and on to metric tons of oligonucleotides
The Latest Trends in Peptides and Oligonucleotides
Octreotide acetate – a complex molecule for a complex disease
Bachem reorganizes responsibilities in the Corporate Executive Committee and increases focus on capacity expansion and efficiency improvement
Glucagon-like peptide 1 (GLP-1)
How can pharma and biotech benefit from strategic alliances?
Bachem increases sales slightly in the first half of 2023
Next events coming up
RNA Leaders Europe Congress 2024
RNA Leaders Europe Congress 2024
Bachem participates at the RNA Leaders Europe Congress 2024, March 13-14 in Basel
USP Workshop 2024
USP Workshop 2024
Bachem is participating at the USP Workshop on Therapeutic Peptides and Oligonucleotides 2024
Full event calendar
Interested in joining at one of our upcoming exhibitions, conferences or webinars? View our full calendar of events.